Naloxone: Opioid Overdose, Prevention, Recognition & Response:

Drug overdose is the leading cause of injury death in the United States, causing more deaths than motor vehicle crashes. The CDC attributes the rise in drug overdose deaths to a higher use of prescription opioid painkillers.

Providing overdose prevention, recognition, and response education to those who have been prescribed opioids, drug users, their families, and their neighbors is a harm reduction intervention that saves lives.

Heroin and other opioid overdoses are particularly amenable to intervention because risk factors are well understood and there is a safe antidote - NALOXONE.

Accreditation Council for Pharmacy Education Information:

This program has been planned and implemented in accordance with the policies of the Accreditation Council for Pharmacy Education through the sponsorship of OSU College of Pharmacy. The OSU College of Pharmacy is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Upon completion of this activity, participants will receive a Certificate of Completion, and a Statement of Credit shall be uploaded to CPE Monitor. Completion requires 1) Registration for the course 2) Completion of all modules and 3) Passing a final exam with 80% or higher and 4) Completion of the program evaluation..

At the completion of this activity, the participant will be able to:
1) Discuss the scope and consequences of the nationwide opioid epidemic and its effects on public health.
2) Identify the risk factors related to opioid drug overdoses.
3) Describe the pharmacist's roles and responsibilities in prescribing naloxone, per state specific guidelines.
4) Accurately calculate morphine milligram equivalents (MME) and properly communicate this information to patients.
5) Identify best practices when engaging with high risk patients, communicating with patients on opioid use, and improving counseling points when dispensing opioids

UAN: 0036-0000-22-035-H01-P
Target Audience: Pharmacists liscensed in Oregon
Activity Type: Application
Activity Release Date: 6/26/2022
Activity Expiration Date: 6/26/2025
Faculty/Contributors: Mark Kantor, RPh; Kevin Russel, RPh, MBA, BCACP; Kenneth Wells, RPh
Declarations: None of the contributors, designers, or peer reviewers for this course have any financial relationships with ineligible companies to disclose